PIMA547798
Infliximab Chimeric Recombinant Human Monoclonal Antibody (cA2 (Infliximab)), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA547798-Each-of-1 | In Stock | ₹ 46,769.50 |
PIMA547798 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,769.50
GST (18%): ₹ 8,418.51
Total Price: ₹ 55,188.01
Antigen
Infliximab Chimeric
Classification
Recombinant Monoclonal
Concentration
1 mg/mL
Formulation
PBS with 0.02% ProClin 300
Gene Accession No.
P08183
Host Species
Human
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
5243
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Isotype
IgG1 κ
Applications
ELISA, Flow Cytometry, Functional Assay, Western Blot
Clone
cA2 (Infliximab)
Conjugate
Unconjugated
Gene
ABCB1
Gene Alias
Remicade; TA-650
Immunogen
Purified recombinant human TNF (rTNF).
Quantity
200 μg
Primary or Secondary
Primary
Target Species
Human
Form
Liquid
Related Products
Description
- Specificity: Binds to soluble and transmembrane forms of TNF-alpha and neutralizes its biological activity
- Does not bind to TNF-beta
- Infliximab with the brand name of Remicade, is a chimeric monoclonal IgG1 antibody
- It binds to TNF-alpha, which is a key proinflammatory cytokine involved in chronic inflammatory diseases
- Infliximab functions as TNF-alpha blocker to disrupt the interaction of TNF-alpha with its receptors.